INIS
patients
100%
doses
55%
chemotherapy
55%
lymphomas
55%
therapy
22%
diseases
22%
risks
11%
stem cells
11%
transplants
11%
refractories
11%
radiotherapy
11%
yields
11%
hodgkins disease
11%
Medicine and Dentistry
Patient
77%
Non-Hodgkin Lymphoma
55%
Inpatient
22%
Therapeutic Procedure
22%
Diseases
11%
Transplantation
11%
Disease Free Survival
11%
Radiation Therapy
11%
Combination Therapy
11%
Hodgkin's Lymphoma
11%
Long Term Survival
11%
Combination Chemotherapy
11%
Chemosensitivity
11%
Salvage Therapy
11%
International Prognostic Index
11%
Stem Cell
11%
Pharmacology, Toxicology and Pharmaceutical Science
High Dose Chemotherapy
88%
Nonhodgkin Lymphoma
55%
Diseases
11%
Disease Free Survival
11%
Hodgkin Disease
11%
Long Term Survival
11%
Biochemistry, Genetics and Molecular Biology
Drug Megadose
44%
Stem Cell
11%
Disease Free Survival
11%
Chemosensitivity
11%
Long Term Survival
11%
Dose
11%